🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

14+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 14 of 14 recruiting trials for “bronchiolitis-obliterans”

EARLY_Phase 1RecruitingNCT07239895 ↗

Treatment of Pediatric Bronchiolitis Obliterans by Airway Basal Stem Cells

🏥 Regend Therapeutics📍 1 site📅 Started Nov 2025View details ↗
Phase 1RecruitingNCT07215923 ↗

A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers

👨‍⚕️ Matthew Kalnik, PhD, Antidote Therapeutics, Inc📍 1 site📅 Started Oct 2025View details ↗
Enrolling by InvitationNCT07023965 ↗

Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)

🏥 Beijing Northland Biotech. Co., Ltd.📍 5 sites📅 Started Jun 2025View details ↗
NARecruitingNCT07002944 ↗

Pulsed Radiofrequency of Shoulder Individual Nerves Versus Brachial Plexus in Management of Chronic Post Mastectomy Shoulder Pain

🏥 Cairo University📍 1 site📅 Started Jun 2025View details ↗
Phase 2RecruitingNCT06476132 ↗

Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

👨‍⚕️ Scott M. Palmer, M.D., M.H.S., Duke University Medical Center: Transplantation📍 10 sites📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT05922761 ↗

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

👨‍⚕️ Corey Cutler, MD, MPH, Dana-Farber Cancer Institute📍 5 sites📅 Started May 2024View details ↗
Phase 4RecruitingNCT05854615 ↗

Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease

👨‍⚕️ Hanafiah Harunarashid, MS, National University of Malaysia📍 1 site📅 Started Jan 2024View details ↗
NARecruitingNCT06140901 ↗

Bronchial Epithelium of Children With Post-infectious Bronchiolitis Obliterans

👨‍⚕️ Julie MAZENQ, PhD, APHP Marseille📍 1 site📅 Started Dec 2023View details ↗
Phase 2RecruitingNCT06018766 ↗

LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.

👨‍⚕️ Steven Hays, MD, University of California, San Francisco📍 1 site📅 Started Aug 2023View details ↗
RecruitingNCT05250037 ↗

The Longitudinal Impact of Respiratory Viruses on Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplantation (The RV-BOS Study)

👨‍⚕️ Guang-Shing Cheng, MD, Fred Hutch/University of Washington Cancer Consortium📍 4 sites📅 Started Mar 2022View details ↗
RecruitingNCT04098445 ↗

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

👨‍⚕️ Stella Davies, MBBS, PhD, MRCP, Children's Hospital Medical Center, Cincinnati📍 9 sites📅 Started Sep 2021View details ↗
RecruitingNCT04099082 ↗

Signature of the Host Response to a Respiratory Viral Infection, in the Prediction of Bronchiolitis Obliterans

🏥 Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Mar 2021View details ↗
RecruitingNCT04604522 ↗

Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans Syndrome

👨‍⚕️ Ajay Sheshadri, M.D. Anderson Cancer Center📍 1 site📅 Started Aug 2020View details ↗
Phase 2RecruitingNCT03805477 ↗

Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation

👨‍⚕️ Katrin Hostettler Haack, PD Dr. med, Clinic of Respiratory Medicine, University Hospital Basel📍 3 sites📅 Started Mar 2019View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →